PAVM News and Press, PAVmed Inc. From 05/26/21

NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, and its major subsidiary Lucid Diagnostics Inc. (“Lucid”), today announced that Lucid&#x...

PAVmed ([[PAVM]] +1.9%) announces that it has received CE Mark certification for its CarpX minimally invasive carpal tunnel device.With CE Mark secured, CarpX may now be marketed in CE Mark European countries, which include the European Economic Area (the EU, Norway, Iceland&#x...

NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced that it has received CE Mark certification for its Carp...

Initial NYU experience in 99 patients demonstrated EsoCheck and EsoGuard capable of detecting esophageal precancer in chronic heartburn patients NEW YORK, May 24, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed&#...

#technicalanalysis provides insights that #fundamentalanalysis cannot.  We can use that to our #advantage in Pavmed Inc. Common Stock (NASDAQ: PAVM).   Using the data offered below we have a real-time example.  Review The technical data for PAVM below, and th...

PAVmed Inc. (PAVM) Q1 2021 Earnings Conference Call May 17, 2021 04:30 PM ET Company Participants Mike Havrilla - Director of Investor Relations Lishan Aklog - Chairman & Chief Executive Officer Dennis McGrath - President & Chief Financial Officer Conference Call Participants Kyle Mik...

Conference call to be held today at 4 :30 P M E D T NEW YORK, May 17, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical d...

Dr. David Poppers to present on his initial experience with Lucid’s EsoCheck and EsoGuard NEW YORK, May 13, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed” or the “Company”), a highly differentiated, multi-product, comm...

The #priceactio n in Pavmed Inc. Common Stock (NASDAQ: PAVM) can help investors find #opportunity and integrate #riskmanagement tools .  Stock Traders Daily has demonstrated that in this article.  Review The plans for PAVM below, and you will see how this works. Ke...

Four new senior executives will support growth strategy focused on multi-channel EsoGuard commercialization NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ ) (“PAVmed” or the “Company”), a hi...